Syndax Pharmaceuticals said a drug to treat idiopathic pulmonary fibrosis missed its primary endpoint in a Phase 2 trial. Shares plunged 19% to $13.34 in after-hours trading on Monday.
Teradyne agreed to invest $300 million in FormFactor as part of a partnership to work on improving semiconductor testing. FormFactor shares gained 3.6% to $134.90.
Navitas Semiconductor released its latest power-delivery board designed for Nvidia infrastructure. The stock was up 4% at $10.39.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.